Business Wire

BRIGHTCOVE

25.6.2020 15:12:07 CEST | Business Wire | Press release

Share
Brightcove Launches Industry-Leading Virtual Event Experiences Solution; Empowering Companies to Quickly and Easily Connect with Audiences Online

Brightcove Inc. (NASDAQ: BCOV), the world’s leading video technology platform, today announced Brightcove Virtual Event Experiences , a solution that allows organizations to deliver high-quality virtual events featuring bold, interactive experiences. Responding to a crucial market need, Brightcove Virtual Event Experiences enables organizations to host events with market-leading video technology to engage with audiences securely and reliably around the world.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200625005507/en/

The adoption of video communications in enterprise organizations is growing at a rapid pace. According to the recent Brightcove Global Video Index , in the first quarter of 2020, video views among enterprise companies increased by 91% year over year, with preliminary year-over-year data from April and May showing viewing increases of nearly 80% and 54%, respectively. Along with this adoption, many in-person events and meetings are moving to online video. With no timetable for the return of large-scale, in-person conferences and events, marketing and event professionals are looking for an in-person alternative, and they are turning to Brightcove for guidance. Recently, Brightcove technology has helped power critical B2B, B2C, and arts/entertainment events, helping organizations scale quickly, easily, and securely while reaching new audiences across the globe, including:

  • ServiceNow Knowledge 2020
  • DocuSign MomentumLive
  • Talkdesk® Opentalk 2020 Virtual
  • NAB Show Express with over 40,000 industry professionals accessing the event since its launch
  • The Dropkick Murphys’ Streaming Outta Fenway concert joined by Bruce Springsteen with over 9 million live and on-demand views to date, raising over $700,000 for charity
  • The Metropolitan Opera's At Home Gala, with more than 40 artists participating from around the world, was watched by more than 750,000 people

The need to engage with customers and prospects is as critical as ever, and organizations expect to deliver innovative and measurable experiences for their audiences in order to maintain communication and engagement. The Brightcove Virtual Events Experience solution empowers companies to take immediate action to ensure that their essential in-person events can continue virtually.

Features include:

  • Branding and User Experience: Control the viewer’s experience and surrounding content by hosting on Brightcove.
  • Increased Value for Sponsors: Demonstrate value to sponsors and exhibitors by offering integrated ads, complete with measurable and tangible analytics.
  • Quality and Global Scale: Enable streaming video to global audiences in a secure environment.
  • Security : Configure a variety of security options beyond password protection and geo-blocking, including SSO and integration with user management solutions.
  • Expertise and support: Engage with Brightcove’s customer experience team and support organization to meet business objectives.

“Like most B2B companies, we had to quickly pivot from an in-person event to a virtual customer conference when COVID-19 hit. Our strategy was to embrace the remote reality but also to create an experience that felt like a performance and developed a sense of community,“ said Kathie Johnson, Chief Marketing Officer, Talkdesk. “To do this, we selected Brightcove as the platform and leveraged its integration partner Pigeonhole for the live polling and social interaction. One analyst who compared B2B customer conferences stated Opentalk 2020 virtual ‘struck the best balance of event duration, content, and engagement.’ The development process with Brightcove was seamless and the response to our program has been extremely positive.”

“The pandemic is video’s evolutionary moment, and as a result, video is now at the forefront of how we communicate with others, how we conduct business, and is enabling us to stay connected even when physically apart,” said Sara Larsen, Chief Marketing Officer, Brightcove. “Events are a place for information sharing, learning, business building, and networking. Now, more than ever, we need events to flourish and connect us in a virtual video experience. Brightcove Virtual Events Experiences allows organizations to deliver exceptional virtual events quickly and securely, without sacrificing the attendee experience. With this solution, we’re not only helping our customers adapt to the changing landscape but also allowing them to stay connected with their audiences with an engaging, innovative video-driven digital experience.”

For more information on Brightcove Virtual Event Experiences, visit: https://www.brightcove.com/en/solutions/virtual-event

About Brightcove Inc. (NASDAQ: BCOV)

We are the people behind the world’s leading video technology platform. With our award-winning technology and services, we help organizations in more than 70 countries meet business challenges and create strategic opportunities by inspiring, entertaining, and engaging their audiences through video.

Since Brightcove was established in 2004, we have consistently pushed boundaries to create a platform for people who are serious about video: one that is robust, scalable, and intuitive. Benefiting from a global infrastructure, unrivalled customer support, an extensive partner ecosystem, and relentless investment in R&D, Brightcove video sets the standard for professional grade video management, distribution, and monetization. To learn more, visit www.brightcove.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye